CD8A and cancer: NKG2DL has been considered as an activating signal on the surface of cancer cells to trigger the cytotoxicity cells including NK cells and CD8+ T cells and was the substantial mechanism of immune surveillance to initiate the immune response to find and eliminate NKG2DL+ tumor cells.